Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,127.20
(
0.47%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
98.81
(
-1.83%
)
Bitcoin
73,861.06
(
-0.11%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: gofishmarko post# 41952

Monday, 02/12/2007 12:33:02 PM

Monday, February 12, 2007 12:33:02 PM

Post# of 257253
>I'm curious about why you think so. Given the FVIII / hemophilia connection, it strikes me as an obvious place to intervene.<

FVIII is an obvious place to intervene with a coagulant, but it’s an unusual place to intervene with an anticoagulant. The usual places to intervene with an anticoagulant are on FXa and/or FIIa.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now